HighTower Advisors LLC Buys 20,139 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

HighTower Advisors LLC grew its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 101.6% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 39,969 shares of the company’s stock after buying an additional 20,139 shares during the quarter. HighTower Advisors LLC’s holdings in Ryan Specialty were worth $2,661,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Hollencrest Capital Management bought a new stake in shares of Ryan Specialty in the third quarter worth $25,000. Assetmark Inc. bought a new stake in Ryan Specialty during the 3rd quarter worth about $34,000. Crewe Advisors LLC acquired a new position in shares of Ryan Specialty during the 2nd quarter worth about $39,000. GAMMA Investing LLC grew its holdings in shares of Ryan Specialty by 106.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,249 shares of the company’s stock valued at $83,000 after acquiring an additional 644 shares in the last quarter. Finally, Rothschild Investment LLC acquired a new stake in shares of Ryan Specialty in the second quarter valued at about $87,000. Institutional investors own 84.82% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares in the company, valued at approximately $884,236.54. This trade represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director David P. Bolger sold 7,055 shares of the stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the sale, the director now owns 78,149 shares in the company, valued at $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company’s stock.

Ryan Specialty Price Performance

Ryan Specialty stock opened at $67.62 on Friday. The company has a market capitalization of $17.71 billion, a price-to-earnings ratio of 87.82, a PEG ratio of 1.54 and a beta of 0.67. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 12 month low of $41.49 and a 12 month high of $75.97. The stock’s 50 day moving average is $70.87 and its 200-day moving average is $64.42.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. During the same period in the prior year, the firm posted $0.32 EPS. The company’s revenue for the quarter was up 20.5% on a year-over-year basis. Equities research analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a dividend of $0.11 per share. This represents a $0.44 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio is 57.14%.

Analyst Ratings Changes

Several brokerages recently commented on RYAN. Bank of America increased their price target on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. The Goldman Sachs Group raised their target price on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. Wells Fargo & Company lifted their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. Finally, Morgan Stanley assumed coverage on shares of Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 target price on the stock. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $73.50.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.